A novel antibody–drug conjugate targeting SAIL for the treatment of hematologic malignancies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel antibody–drug conjugate targeting SAIL for the treatment of hematologic malignancies
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 5, Issue 5, Pages e316-e316
Publisher
Springer Nature
Online
2015-05-29
DOI
10.1038/bcj.2015.39
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantitative Assessment of Antibody Internalization with Novel Monoclonal Antibodies against Alexa Fluorophores
- (2015) Sindy Liao-Chan et al. PLoS One
- Discovery of Fully Human Anti-MET Monoclonal Antibodies with Antitumor Activity against Colon Cancer Tumor Models In Vivo
- (2015) Edward Htun van der Horst et al. NEOPLASIA
- Antibody-drug conjugates: an emerging modality for the treatment of cancer
- (2014) Mauricio Leal et al. Annals of the New York Academy of Sciences
- SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
- (2013) M. S. Kung Sutherland et al. BLOOD
- Antibody–drug conjugates: current status and future directions
- (2013) Heidi L. Perez et al. DRUG DISCOVERY TODAY
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- Antibody-drug conjugates
- (2013) Alain Beck et al. mAbs
- DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
- (2013) D. Li et al. MOLECULAR CANCER THERAPEUTICS
- Diffuse large B-cell lymphoma—treatment approaches in the molecular era
- (2013) Mark Roschewski et al. Nature Reviews Clinical Oncology
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Antibody-Drug Conjugates in Cancer Therapy
- (2012) Eric L. Sievers et al. Annual Review of Medicine
- Drug-conjugated antibodies for the treatment of cancer
- (2012) John M. Lambert BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Identification and characterization of a novel transcriptional target of RUNX1/AML1 at the onset of hematopoietic development
- (2011) C. Ferreras et al. BLOOD
- CD30-targeted antibody therapy
- (2011) Anas Younes CURRENT OPINION IN ONCOLOGY
- RNAscope
- (2011) Fay Wang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Global quantification of mammalian gene expression control
- (2011) Björn Schwanhäusser et al. NATURE
- Less label, more free: Approaches in label-free quantitative mass spectrometry
- (2011) Karlie A. Neilson et al. PROTEOMICS
- Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma
- (2010) A G Polson et al. LEUKEMIA
- Anti-leukemic activity of Lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia
- (2010) May Kung Sutherland et al. mAbs
- The pros and cons of peptide-centric proteomics
- (2010) Mark W Duncan et al. NATURE BIOTECHNOLOGY
- Antibody-Drug Conjugates for the Treatment of Non-Hodgkin's Lymphoma: Target and Linker-Drug Selection
- (2009) A. G. Polson et al. CANCER RESEARCH
- Antibody-Drug Conjugate Targets
- (2009) B. Teicher CURRENT CANCER DRUG TARGETS
- Potent antibody drug conjugates for cancer therapy
- (2009) Peter D Senter CURRENT OPINION IN CHEMICAL BIOLOGY
- Correlation of mRNA and protein in complex biological samples
- (2009) Tobias Maier et al. FEBS LETTERS
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now